Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on May 03, 2024 - 2:22PM >>   ABB 6689 [ 0.14 ]ACC 2527.1 [ -0.03 ]AMBUJA CEM 620.7 [ -0.75 ]ASIAN PAINTS 2925.8 [ -1.61 ]AXIS BANK 1139.4 [ -0.90 ]BAJAJ AUTO 9136.7 [ 0.36 ]BANKOFBARODA 274.85 [ -1.59 ]BHARTI AIRTE 1264.3 [ -3.20 ]BHEL 304.15 [ 3.93 ]BPCL 627.95 [ -1.08 ]BRITANIAINDS 4743 [ -0.36 ]CIPLA 1423 [ 0.24 ]COAL INDIA 467.7 [ 3.19 ]COLGATEPALMO 2793.85 [ -0.62 ]DABUR INDIA 530.05 [ 1.10 ]DLF 872.9 [ -2.56 ]DRREDDYSLAB 6399.95 [ 1.78 ]GAIL 203.05 [ -0.95 ]GRASIM INDS 2475.7 [ 1.70 ]HCLTECHNOLOG 1342.5 [ -1.32 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1512.9 [ -1.31 ]HEROMOTOCORP 4548.4 [ -0.31 ]HIND.UNILEV 2212 [ -0.60 ]HINDALCO 644.7 [ 0.51 ]ICICI BANK 1137.2 [ -0.24 ]IDFC 119 [ -1.94 ]INDIANHOTELS 569 [ -1.21 ]INDUSINDBANK 1481.4 [ -1.61 ]INFOSYS 1410.8 [ -0.29 ]ITC LTD 433.7 [ -1.23 ]JINDALSTLPOW 929.45 [ -1.32 ]KOTAK BANK 1552.85 [ -1.46 ]L&T 3497 [ -2.80 ]LUPIN 1650.3 [ 0.15 ]MAH&MAH 2188.1 [ 0.17 ]MARUTI SUZUK 12453.35 [ -2.66 ]MTNL 37.78 [ -0.68 ]NESTLE 2441.35 [ -2.79 ]NIIT 104.4 [ -0.81 ]NMDC 266.7 [ 3.19 ]NTPC 361.05 [ -2.25 ]ONGC 285.6 [ 1.04 ]PNB 135.15 [ -2.07 ]POWER GRID 309.85 [ -1.15 ]RIL 2844.95 [ -2.97 ]SBI 827.2 [ -0.34 ]SESA GOA 411.25 [ 0.13 ]SHIPPINGCORP 221 [ -2.88 ]SUNPHRMINDS 1511.05 [ -0.48 ]TATA CHEM 1089.5 [ -1.02 ]TATA GLOBAL 1096.9 [ 0.53 ]TATA MOTORS 1009.65 [ -1.78 ]TATA STEEL 166.35 [ -0.60 ]TATAPOWERCOM 453.85 [ -0.84 ]TCS 3822.4 [ -1.07 ]TECH MAHINDR 1246.75 [ -1.59 ]ULTRATECHCEM 9823.4 [ -1.58 ]UNITED SPIRI 1194.4 [ 0.01 ]WIPRO 455.35 [ -0.42 ]ZEETELEFILMS 142.8 [ -0.76 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 506690ISIN: INE351A01035INDUSTRY: Pharmaceuticals

BSE   ` 600.20   Open: 585.00   Today's Range 564.85
604.00
+15.20 (+ 2.53 %) Prev Close: 585.00 52 Week Range 365.35
606.85
Year End :2022-03 

Unichem Laboratories LimitedReport on the Audit of the Standalone Financial Statements

Qualified Opinion

1. We have audited the accompanying standalone financial statements of Unichem Laboratories Limited (“the Company") which comprise the Balance Sheet as at 31st March, 2022, the Statement of Profit and Loss (including other comprehensive income), the Statement of Changes in Equity and the Statement of Cash Flows for the year ended on that date and a summary of significant accounting policies and other explanatory information (hereinafter referred to as “standalone financial statements”).

2. In our opinion and to the best of our information and according to the explanations given to us, except for the effects of the matter described in the Basis for Qualified Opinion paragraph below, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 (“the Act”) in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards (Ind AS) prescribed under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as amended, and other accounting principles generally accepted in India, of the state of affairs of the Company as at 31 st March, 2022, the loss and total comprehensive income, changes in equity and its cash flows for the year ended on that date.

Basis for Qualified Opinion

3. We draw attention to note 38 of standalone financial statements regarding the EU fine matter and the Company financial exposure of ' 12,267.33 lakhs in the subsidiary (Niche Generics Limited, UK) in respect of which no provision for impairment is made in view of uncertainty as regards the EU fine matter. The impact on the standalone financial statements of including the above provision would be that the Company would show loss for the year of ' 12,273.09 lakhs and balance in other equity of ' 253,528.64 lakhs as at balance sheet date as against the reported figures of loss for the year of ' 5.76 lakhs and other equity of ' 265,795.97 lakhs.

4. We conducted our audit of the standalone financial statements in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the Auditor’s Responsibilities for the Audit of the standalone financial statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the standalone financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion on the standalone financial statements.

Key Audit Matters

5. Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial statements of the current period. These matters were addressed in the context of our audit of the standalone financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. In addition to the matter described in the Basis for Qualified Opinion, we have determined the matter described below to be the key audit matter to be communicated in our report.

5.1. Impairment test of investment in subsidiary at Ireland

Investment in subsidiary is carried in the Company’s standalone financial statements at cost less impairment. The carrying value of investment made by the Company in its subsidiary (Unichem Laboratories Limited, Ireland) as per standalone financial statements is aggregating ' 2,104.84 lakhs as at 31st March, 2022. In case of this subsidiary, there are accumulated losses and low net-worth as at balance sheet date. Considering the overall exposure in this subsidiary, need for impairment test is a key audit matter. Based on the financial projections of the above subsidiary, the management is of the view that recoverable amount is higher than carrying value of these investments and there is no impairment of investment as at balance sheet date. For the purpose of our audit, we have considered the following aspect:

a. Analytical review of gross margins earned by the subsidiary.

b. Discussion with management for business outlook (including future financial projections of the above subsidiaries) and plans for overall turnaround of the subsidiary.

c. Evaluated the performance in the current year as compared to last year and prior year achievement as compared to the budget.

d. Discussion with the auditor of subsidiary for the basis on which they have concluded that there is no impairment of assets in the books of subsidiary

Based on our evaluation of management estimates, other information & discussion with the management, we agree with the management views and estimates and conclude that no provision for impairment is required as at date of our audit report.

Refer to note 6.1 of the standalone financial statements.

Information Other than the Standalone Financial Statements and Auditor’s Report Thereon

6. The Company’s Board of Directors is responsible for the preparation of the other information. The other information comprises the information included in the Management Discussion and Analysis, Board’s Report including Annexures to Board’s Report, Corporate Governance, Business Responsibility Report and Shareholder’s Information, but does not include the standalone financial statements and our auditor’s report thereon.

Our opinion on the standalone financial statements does not cover the other information and we will not express any form of assurance conclusion thereon.

In connection with our audit of the standalone financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements or our knowledge obtained during the course of our audit or otherwise appears to be materially m isstated.

If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report the fact. We have nothing to report in this regard.

Management’s Responsibility for the Standalone Financial Statements

7. The Company’s Board of Directors is responsible for the matters stated in Section 134(5) of the Act with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position, financial performance, total comprehensive income, changes in equity and cash flows of the Company in accordance with the Ind AS and accounting principles generally accepted in India. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, the Board of Directors is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors are also responsible for overseeing the Company’s financial reporting process.

Auditor’s Responsibilities for the Audit of the Standalone Financial Statements

8. Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. M isstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the standalone financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under section 143(3)(i) of the Companies Act, 2013, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls system in place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the management.

• Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the standalone financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the standalone financial statements, including the disclosures, and whether the standalone financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the standalone financial statements that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the financial statements may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the standalone financial statements.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of standalone financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

9. As required by the Companies (Auditor's Report) Order, 2020 (the “Order”) issued by the Central Government of India in terms of Section 143(11) of the Act, we give in the “Annexure I” a statement on the matters specified in paragraphs 3 and 4 of the Order.

10. As required by Section 143 (3) of the Act, we report that:

a. Except in respect of matter specified in the Basis for Qualified Opinion paragraph above, we have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purposes of our audit;

b. Except for the effects of the matter described in the Basis for Qualified Opinion paragraph above, in our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books;

c. The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, Statement of Changes in Equity and the Statement of Cash Flow Statement dealt with by this Report are in agreement with the books of account;

d. Except for the effects of the matter described in the Basis for Qualified Opinion paragraph above, in our opinion, the aforesaid standalone financial statements comply with the Ind AS specified under Section 133 of the Act;

e. The matter described in the Basis for Qualified Opinion paragraph above, in our opinion, may not have an adverse impact on the functioning of the Company;

f. On the basis of the written representations received from the directors as on 31 st March, 2022 taken on record by the Board of Directors, none of the directors are disqualified as on 31 st March, 2022 from being appointed as a director in terms of Section 164(2) of the Act;

g. With respect to the adequacy of internal financial controls over financial reporting of the Company and the operating effectiveness of such controls, refer to our separate report given in “Annexure II”. Our report expresses an unmodified opinion on the adequacy and operating effectiveness of the Company’s internal financial controls over financial reporting;

h. The qualification relating to the maintenance of accounts and other matters connected therewith are as stated in the Basis for Qualified Opinion paragraph above;

i. With respect to the other matters to be included in the Auditor’s Report in accordance with the requirements of section 197(16) of the Act:

In our opinion and to the best of our information and according to the explanations given to us, the remuneration paid by the Company to its directors during the year is in accordance with the provisions of section 197 of the Act; and

j. With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, as amended, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its standalone financial statements -Refer note 37(A)(i), 37(A)(ii), 37(B)(i), 37(B)(iii) and 37(B)(iv) to the standalone financial statements;

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses; and

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company.

iv. (a) The Management has represented that, to the best of its knowledge and belief, no funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person or entity, including foreign entity (“Intermediaries”), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries;

(b) The Management has represented, that, to the best of its knowledge and belief, no funds have been received by the Company from any person or entity, including foreign entity (“Funding Parties”), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries;

(c) Based on the audit procedures that have been considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the representations under sub-clause (i) and (ii) of Rule 11 (e), as provided under (a) and (b) above, contain any material misstatement. Also, refer note 60 of the standalone financial statement.

v. As stated in note 18 to the standalone financial statements:

(a) The final dividend proposed in the previous year, declared and paid by the Company during the year is in accordance with Section 123 of the Act.

(b) The Board of Directors of the Company have proposed final dividend for the year which is subject to the approval of the members at the ensuing Annual General Meeting. The amount of dividend proposed is in accordance with section 123 of the Act.

For N. A. Shah Associates LLP

Chartered Accountants

Firm's Registration No.: 116560W/W100149

Milan Mody

Partner

Membership No.: 103286 UDIN.: 22103286AJSRSQ4129

Place: Mumbai Date: 27th May, 2022